{"title":"Functional and morphological improvement of significant non-culprit coronary artery stenosis by LDL-C reduction with a PCSK9 antibody: Rationale and design of the randomized FITTER trial","link":"https://www.sciencedirect.com/science/article/pii/S2405844024141084?dgcid=rss_sd_all","date":null,"content":"<p>Publication date: 15 October 2024</p><p><b>Source:</b> Heliyon, Volume 10, Issue 19</p><p>Author(s): Frans B. Mensink, Jonathan Los, Rohit M. Oemrawsingh, Clemens von Birgelen, Alexander Ijsselmuiden, Martijn Meuwissen, Jin M. Cheng, Diederik F. van Wijk, Pieter C. Smits, Valeria Paradies, Dirk J. van der Heijden, Himanshu Rai, Tim JF. ten Cate, Cyril Camaro, Peter Damman, Lokien X. van Nunen, Aukelien C. Dimitriu-Leen, Marleen H. van Wely, Aysun Cetinyurek-Yavuz, Robert A. Byrne</p>","author":"","siteTitle":"ScienceDirect Publication: Heliyon","siteHash":"f7bd7e3f1869707615b3e54fb4ebc4eb7c817c729fd5ad33a7fd4ed65328d468","entryHash":"f5d1b06120f8a8e04da9a7c32845171e06335cf1bf7a40a098ee1891d2303922","category":"Interdisciplinary"}